Welcome to
On Feet Nation
freeamfva Online
Posted by Perfect Jammer on September 9, 2024 at 11:21pm 0 Comments 0 Likes
GSM war für den größten Teil der Welt der dominierende Standard für digitale 2G-Mobiltelefone. Es bestimmt die Art und Weise, wie Mobiltelefone mit dem landgestützten Netzwerk von Türmen kommunizieren. Der Mobilfunkstandard ist weltweit implementiert. Es gibt insgesamt 14 GSM-störsender-Frequenzbänder, die sowohl voreingestellte als auch dynamische Kanalzuordnungen enthalten. Die Frequenzbereiche für jedes dieser Frequenzbänder sind…
ContinueThe global Cellular Immunotherapy Market size is expected to reach USD 37.97 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 22.41% during the forecast period, driven by the growing government support for innovative therapies research, rising prevalence of cancer, development of advanced cell-based immunotherapies, and increasing R&D investment by global players.
Growing support from government organizations and research institutes including the National Cancer Institute (NCI) and Center of Excellence in Immunology (CEI) for cellular immunotherapies research is one of the major factors driving the market growth. For instance, the CEI pulls out experts from other institutes such as NCI and NIH to promote the growth of immunotherapy for the treatment of cancer. Also, the Surgery Branch of the National Cancer Institute's Center for Cancer Research (CCR) is committed to the innovation of novel immunotherapies for the treatment of cancer patients.
The rising number of M&As, collaborations, acquisitions, and funding is a major trend observed in the market. M&A and collaboration help companies expand their existing product portfolio and regional reach in a short period. For instance, in March 2021, TrakCel received funding from Labcorp and AmerisourceBergen for cellular therapy orchestration research and global expansion. Also, in April 2020, Kite (a Gilead Company) and Teneobio, Inc. entered into a license agreement through which Kite will receive exclusive rights to specific antibodies targeted to B-cell maturation antigen (BCMA). Thus, such M&A and collaborations are expected to boost the market growth.
A substantial number of cellular immunotherapy companies are engaged in new product launches, pertaining to licensing, collaborations, & acquisitions, and regional expansion. Some of the key companies in the market are Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences Inc. (Kite Pharma); F. Hoffmann-La Roche Ltd.; and Johnson & Johnson. These companies are adopting various business models to gain a competitive advantage. For instance, in February 2021, Novartis secured approval for the first Australian commercial CAR-T manufacturing site for Kymriah. With this approval, the company would be able to develop Kymriah in Australia, thereby providing easy access to Australian patients.
The COVID-19 pandemic has had a high impact on the market. Owing to stringent regulations to curb the pandemic, a slowdown in clinical trials, approval of new drugs, and delayed cancer diagnosis have been observed, affecting the industry's growth amid the pandemic. However, in several countries, the effect of COVID-19 declined after the third quarter of 2021, which helped the market regain traction.
Related Press Release@ Cellular Immunotherapy Market Report
List of Key Players in the Cellular Immunotherapy Market
Cellular Immunotherapy Market Report Highlights
Report Attribute |
Details |
Market size value in 2022 |
USD 7.5 billion |
Revenue forecast in 2030 |
USD 37.97 billion |
Growth Rate |
CAGR of 22.41% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2018 - 2020 |
Forecast period |
2022 - 2030 |
Related Reports@
Cellular Immunotherapy Market Segmentation
Grand View Research has segmented the global cellular immunotherapy market based on therapy type, indication, end-use, and region:
Cellular Immunotherapy Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
Cellular Immunotherapy Indication Outlook (Revenue, USD Million, 2018 - 2030)
Cellular Immunotherapy End-use Outlook (Revenue, USD Million, 2018 - 2030)
Cellular Immunotherapy Regional Outlook (Revenue, USD Million, 2018 - 2030)
UAE
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation